Alastair J. J. Wood
Director/Board Member at Symphony Evolution, Inc.
Profile
Alastair J.
J.
Wood is currently a Director at Symphony Evolution, Inc., Critical Path Institute, National Institutes of Health, a Member-Development Committee at Symphony Dynamo, Inc., and a Professor at Weill Cornell Medical College.
He previously worked as a Director at Oncotelic Therapeutics, Inc. from 2008 to 2013, a Director at Agenus, Inc., a Managing Director at Symphony Capital LLC from 2006 to 2009, and a Member-Development Committee at Symphony Allegro, Inc. and Symphony Icon, Inc. He obtained a doctorate degree from the University of St. Andrews.
Alastair J. J. Wood active positions
Companies | Position | Start |
---|---|---|
Symphony Evolution, Inc.
Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Symphony Evolution, Inc. engages in the manufacture of biopharmaceutical drugs. It develops therapeutics to treat cancer and diabetic nephropathy. The company was founded on October 19, 2006 and is headquartered in Wilmington, DE. | Director/Board Member | - |
Symphony Dynamo, Inc.
Symphony Dynamo, Inc. Pharmaceuticals: MajorHealth Technology Symphony Dynamo, Inc. manufactures biopharmaceutical drugs. It was created to advance TLR-9 based therapeutics in hepatitis B therapy and hepatitis C therapy and cancer. The company was founded in 2002 and is headquartered in Rockville, MD. | Corporate Officer/Principal | 2011-03-01 |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Director/Board Member | 2011-03-01 |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 2011-03-06 |
Weill Cornell Medical College | Corporate Officer/Principal | 2011-03-06 |
Former positions of Alastair J. J. Wood
Companies | Position | End |
---|---|---|
ONCOTELIC THERAPEUTICS, INC. | Director/Board Member | 2013-07-15 |
AGENUS INC. | Director/Board Member | 2006-09-13 |
Symphony Icon, Inc.
Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Symphony Icon, Inc. engages in the manufacture of pharmaceutical products. The company was founded in June 2007 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - |
Symphony Allegro, Inc.
Symphony Allegro, Inc. Pharmaceuticals: MajorHealth Technology Symphony Allegro, Inc. manufactures biopharmaceutical drugs. It develops clinical trials for the treatment of schizophrenia, bipolar, migraine, and panic attack disorders. The company was founded in 2006 and is headquartered in Rockville, MD. | Corporate Officer/Principal | - |
░░░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Training of Alastair J. J. Wood
University of St. Andrews | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
AGENUS INC. | Health Technology |
ONCOTELIC THERAPEUTICS, INC. | Health Technology |
Private companies | 7 |
---|---|
Symphony Capital LLC
Symphony Capital LLC Investment ManagersFinance Symphony Capital LLC (Symphony Capital) is a private equity firm founded in 2002. The firm is headquartered in New York. | Finance |
Symphony Evolution, Inc.
Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Symphony Evolution, Inc. engages in the manufacture of biopharmaceutical drugs. It develops therapeutics to treat cancer and diabetic nephropathy. The company was founded on October 19, 2006 and is headquartered in Wilmington, DE. | Health Technology |
Symphony Dynamo, Inc.
Symphony Dynamo, Inc. Pharmaceuticals: MajorHealth Technology Symphony Dynamo, Inc. manufactures biopharmaceutical drugs. It was created to advance TLR-9 based therapeutics in hepatitis B therapy and hepatitis C therapy and cancer. The company was founded in 2002 and is headquartered in Rockville, MD. | Health Technology |
Symphony Allegro, Inc.
Symphony Allegro, Inc. Pharmaceuticals: MajorHealth Technology Symphony Allegro, Inc. manufactures biopharmaceutical drugs. It develops clinical trials for the treatment of schizophrenia, bipolar, migraine, and panic attack disorders. The company was founded in 2006 and is headquartered in Rockville, MD. | Health Technology |
Symphony Icon, Inc.
Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Symphony Icon, Inc. engages in the manufacture of pharmaceutical products. The company was founded in June 2007 and is headquartered in Rockville, MD. | Health Technology |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022. | Commercial Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
- Stock Market
- Insiders
- Alastair J. J. Wood